NCT06237114Completed
Novel Robotic Prostatectomy Technique for Early Urinary Continence
Phase II Clinical Trial to Evaluate the Early Return of Urinary Continence Utilizing a Novel Hybrid Transvesical Adapted Retzius Sparing Robotic Assisted Radical Prostatectomy Technique
Source: ClinicalTrials.gov · Last updated 18 Apr 2025
Brief summary (registry, in English)
The goal of this a single arm prospective study is to evaluating the 3-month return of urinary continence outcomes of patients undergoing the transvesical retzius sparing robotic radical prostatectomy (TRS-RALP) for standard of care surgical prostate removal for treatment of prostate cancer. The main question it aims: To have patients respond to questionnaires to collect exploratory data on patient's quality of life (QoL; EuroQol-5 Dimension 5-Level \[EQ-5D-5L\] and prostate cancer related urinary, bowel, and sexual function questionnaires (Expanded Prostate cancer Index Composite for Clinical Practice (EPIC-CP), at their standard of care perioperative visits at baseline and at 4 weeks, 3- and 6-months post operatively.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 24 Jan 2024
- Start date
- 8 Mar 2024
- Primary completion date
- 8 Mar 2025
- Lead sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
- Diseases
- Prostate cancer
- NCT number
- NCT06237114
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 8 Mar 2024 to the primary completion date, 8 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with previous pelvic surgery
- Patients with previous pelvic radiotherapy
- Patient with previous focal therapy for prostate cancer
- Patients undergoing a concomitant cancer surgery
Age
- Patients aged \< 18 years at diagnosis
Other
- Legally incapable patients
- Patients who are unable to receive information about the study in a language they understand
- Patients who are unable to complete questionnaires and have no companion to help complete them
Who the study is looking for
- Patients undergoing standard of care robotic radical prostatectomy for localized prostate cancer
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jewish General Hospital Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.